China Botanic Pharmaceutical (CBP) Reports Q2 Earnings of $0.21; Reaffirms Outlook
Tweet Send to a FriendGet Alerts CBP Hot Sheet
Trade CBP Now!
China Botanic Pharmaceutical (NYSE: CBP) reported Q2 EPS of $0.21, versus $0.19 reported last year. Revenue for the quarter came in at $23 million, versus $18.9 million reported last year.
China Botanic Pharmaceutical reaffirmed FY2012 guidance.
For earnings history and earnings-related data on China Botanic Pharmaceutical (CBP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
China Botanic Pharmaceutical reaffirmed FY2012 guidance.
For earnings history and earnings-related data on China Botanic Pharmaceutical (CBP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Aeropostale, Inc. (ARO) Tops Q1 EPS by 1c; Guide for Wide Q2 Loss
- Nordson Corp (NDSN) Reports In-Line Q2 EPS, Q3 Guidance Falls Short
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
